FIELD: medicine, abdominal surgery.
SUBSTANCE: after performing operative interference and sanitation of patient's abdominal cavity the latter should be introduced with sterile phosphate-citrate buffer solution at pH being5.6 at the quantity of 1 l to be applied for washing the organs of abdominal cavity. Then its greater part should be removed by keeping up to 200 ml solution in abdominal cavity. The present innovation enables to activate thrombin being a constituent of an exudates in abdominal cavity and inhibits the development of adhesion's primary component - fibrin.
EFFECT: higher efficiency of prophylaxis.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREVENTIVE METHOD OF INTRAPERITONEAL ADHESIONS FORMATIONS CAUSED BY SURGERIES OF BOWELS | 2006 |
|
RU2325169C1 |
| WAY PREVENTING POSTOPERATIVE ADHESIONS FORMATION | 2007 |
|
RU2363476C1 |
| METHOD FOR TREATMENT OF EXTENSIVE PERITONITIS | 2007 |
|
RU2339368C1 |
| METHOD FOR PREVENTING CONNECTIVE TISSUE ADHESION | 1996 |
|
RU2161959C2 |
| METHOD FOR PREVENTING POSTSURGICAL SEROUS CAVITY COMMISSURE FORMATION | 2002 |
|
RU2225171C2 |
| METHOD FOR PREDICTION OF POSTOPERATIVE ADHESIONS OF THE PERITONEUM IN THE EXPERIMENT | 2018 |
|
RU2696828C1 |
| METHOD FOR TREATING THE CASES OF COMMISSURE DISEASE | 1998 |
|
RU2177741C2 |
| METHOD OF PREVENTING POSTOPERATIVE COMMISSURAL PROCESS IN ABDOMINAL CAVITY | 2009 |
|
RU2432944C2 |
| METHOD OF ABDOMINAL ADHESIONS PREVENTION | 2010 |
|
RU2447848C2 |
| COMPOUNDS FOR ADHESION TREATMENT OR PREVENTION, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND METHOD FOR ADHESION PROCESS PREVENTION AND TREATMENT | 2016 |
|
RU2624228C1 |
